University of Missouri
Columbia, Missouri, 65201, United States
NCT Number: NCT04421690
The purpose of this research is to look at the effects of computerized cognitive training on anxiety, sleep, mental abilities (cognition), and other aspects of daytime functioning, such as arousal.
Looking for future studies?
Notify Me45 year–59 year
All sexes
Interventional
Not applicable
Columbia, Missouri, 65201, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants (n=15) will complete computerized cognitive training games and activities online 3 times/week for 8 weeks.
Participants (n=15) will receive computerized trivia questions to answer and submit 3 times/week for 8 weeks.
Time frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., processing speed).
Time frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., attention).
Time frame: Up to 10 weeks
Complete computerized tasks. These tasks will measure cognitive functions (e.g., executive function).
Time frame: Up to 10 weeks
A 25-item questionnaire. Participants rate from 0 (never) to 4 (very often) frequency of cognitive errors. Higher scores indicate lower cognitive self-efficacy.
Time frame: Up to 10 weeks
5- item questionnaire that assess anxiety related to the Coronavirus.
Time frame: Up to 10 weeks
Inventory that asks respondents to rate how true 20 self-descriptive statements (e.g., I feel calm) are on a 4-point scale (1 = not at all, 4 = very much so). Typically, respondents are asked to rate statements according to how they generally feel (trait-anxiety scale) and how they feel in the current moment (state-anxiety scale). Total scores range from 20 to 80, with higher scores indicating greater maladjustment.
Time frame: Up to 10 weeks
During the intervention phase the cognitive training group will play games and will need to log the days and duration played.
Time frame: Up to 10 weeks
19-item questionnaire that assesses preference for morning, afternoon, and evening activities. Total score reflects degree of "morningness" or "eveningness" type.
Time frame: Up to 10 weeks
Perceived Stress Scale is a self-report measure of how life situations are perceived as stressful. The scale consists of 15 items corresponding to everyday situation and participants are asked to rate on a likert scale from 0 (never) to 4 (very often) how often they felt or thought a specific way. Higher scores correspond to higher perceived stress.
Time frame: Up to 10 weeks
Pre-sleep Arousal Scale is a 16-item self-report questionnaire comprising both cognitive and somatic manifestations of arousal.
Time frame: Up to 10 weeks
Arousal Predisposition Scale is a 12-item inventory that has been designed to measure the degree to which an individual experiences arousal. Higher scores indicate greater predisposition to arousal.
Time frame: Up to 10 weeks
Questionnaire assessing the experience of the game.
Time frame: Up to 10 weeks
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.
Time frame: Baseline
10-item questionnaire that assess the frequency of alcohol use and problems associated with alcohol use over the past year.
Time frame: Up to 10 weeks
7- item questionnaire assessing the different kinds of physical activities that the participant does as pat of their everyday life.
Time frame: Baseline
10 question assessment measuring personality.
Time frame: Up to 10 weeks
20- item questionnaire assessing the effects of news and social media on perception of COVID-19.
Time frame: Up to 10 weeks
16- item questionnaire about the use of the intervention.
Time frame: Baseline
This questionnaire asks about participants' ability to perform a number of tasks with a computer. Will be examined as a covariate.
Time frame: Up to 10 weeks
Brief self-report measure of current perception of insomnia symptom severity, distress and daytime impairment. Commonly used in insomnia treatment outcome research.
Time frame: Up to 10 weeks
21-item inventory that asks respondents to rate on a scale of 0 (no depressive feelings) to 3 (most depressive feelings) their feelings towards various aspects of daily living/situations. Higher total scores indicate worse depressive symptoms.
Time frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency, wake time after sleep onset, total sleep time, and sleep quality.
Time frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep onset latency
Time frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure wake time after sleep onset
Time frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure total sleep time
Time frame: Up to 10 weeks
Online diaries completed each morning (~5 mins); diaries measure sleep quality
University of Missouri-Columbia
Other
Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study (COGMA)
Acronym: COGMA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT03585010
Anxiety Disorder of Childhood, Anxiety Disorders
New Haven, Connecticut, United States
View Trial DetailsNCT07452835
Anxiety Disorders, Depressive Disorder
Cairo, Menofia, Egypt
View Trial DetailsNCT06046170
Anxiety, Anxiety Disorders
Baltimore, Maryland, United States
View Trial Details